SANTINI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 697
EU - Europa 182
AS - Asia 66
Totale 945
Nazione #
US - Stati Uniti d'America 697
GB - Regno Unito 48
SE - Svezia 47
HK - Hong Kong 32
IT - Italia 32
DE - Germania 24
CN - Cina 20
BG - Bulgaria 8
UA - Ucraina 7
FI - Finlandia 6
TR - Turchia 6
VN - Vietnam 4
FR - Francia 3
IE - Irlanda 2
IN - India 2
LT - Lituania 2
MY - Malesia 2
RU - Federazione Russa 2
RO - Romania 1
Totale 945
Città #
Fairfield 126
Woodbridge 77
Chandler 66
Seattle 61
Ashburn 58
Houston 46
Cambridge 45
Wilmington 45
Southend 38
Nyköping 37
Hong Kong 32
Dearborn 13
San Diego 13
Jacksonville 11
Ann Arbor 10
Modena 9
Bremen 8
New York 8
Princeton 8
Sofia 8
Shanghai 7
London 6
Helsinki 5
Izmir 5
Milan 5
Beijing 4
Dong Ket 4
Eugene 4
Frankfurt am Main 4
Norwalk 3
Rome 3
Arzignano 2
Aversa 2
Dublin 2
Klaipėda 2
Nanjing 2
Redwood City 2
Augusta 1
Boardman 1
Bologna 1
Falkenstein 1
Fucecchio 1
Grafing 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Hanover 1
Iasi 1
Jiaxing 1
Jinan 1
Moscow 1
Redmond 1
Rende 1
Saint Louis 1
Sassuolo 1
Shenyang 1
Volgograd 1
Totale 801
Nome #
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 193
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 168
Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium 142
Multicentric prospective study of validation of angiogenesis polymorphisms in HCC patients treated with sorafenib. INNOVATE study 121
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results 99
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 92
Small bowel carcinomas in celiac or Crohn's disease: Distinctive histophenotypic, molecular and histogenetic patterns 79
Liver metastases from carcinoid tumor: Imaging patterns 49
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 16
Totale 959
Categoria #
all - tutte 4.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 16 24
2019/2020127 12 5 3 8 11 24 22 15 14 5 7 1
2020/2021296 21 1 21 37 87 16 25 27 12 23 11 15
2021/2022175 10 18 9 6 3 10 10 11 21 8 55 14
2022/2023176 18 27 10 17 24 23 3 13 22 0 6 13
2023/2024103 5 8 6 12 23 2 18 20 0 8 1 0
Totale 959